These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30212434)

  • 21. Does HIV Pre-Exposure Prophylaxis Modify the Effect of Partnership Characteristics on Condom Use? A Cross-Sectional Study of Sexual Partnerships Among Men Who Have Sex with Men in San Francisco, California.
    Prescott MR; Hern J; Petersen M; Santos GM
    AIDS Patient Care STDS; 2019 Apr; 33(4):167-174. PubMed ID: 30932698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
    Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
    Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-Exposure Prophylaxis (PrEP) Use and Condomless Anal Sex: Evidence of Risk Compensation in a Cohort of Young Men Who Have Sex with Men.
    Newcomb ME; Moran K; Feinstein BA; Forscher E; Mustanski B
    J Acquir Immune Defic Syndr; 2018 Apr; 77(4):358-364. PubMed ID: 29210834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community-Based Care in the ANRS-IPERGAY Trial: The Challenges of Combination Prevention.
    Puppo C; Mabire X; Cotte L; Castro DR; Spire B; Cua E; Pialoux G; Monti MS; Pasquet A; Raffi F; Molina JM; Préau M;
    AIDS Educ Prev; 2019 Jun; 31(3):259-272. PubMed ID: 31145006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemsex in HIV pre-exposure prophylaxis users: Assessment of mood disorders and addictive behavior.
    Peyriere H; Jacquet JM; Peries M; Tribout V; Broche B; Mauboussin JM; Makinson A; Perrollaz C; Ferreyra M; Rouanet I; Montoya-Ferrer A; El-Majjaoui S; Corriol-Bonifas F; Fraisse T; Grau F; Laureillard D; Nagot N; Reynes J; Donnadieu-Rigole H
    Fundam Clin Pharmacol; 2023 Jun; 37(3):639-649. PubMed ID: 36403123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NZPrEP Demonstration Project: protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) to determine feasibility, acceptability, adverse and behavioural effects of PrEP provision to gay and bisexual men in publicly funded sexual health clinics in Auckland, New Zealand.
    Azariah S; Saxton P; Franklin R; Forster R; Werder S; Jenkins R
    BMJ Open; 2019 Jun; 9(6):e026363. PubMed ID: 31248921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bridging Awareness and Acceptance of Pre-Exposure Prophylaxis Among Men Who Have Sex With Men and the Need for Targeting Chemsex and HIV Testing: Cross-Sectional Survey.
    Kwan TH; Lee SS
    JMIR Public Health Surveill; 2019 Jul; 5(3):e13083. PubMed ID: 31271148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-exposure prophylaxis among men who have sex with men in the Amsterdam Cohort Studies: Use, eligibility, and intention to use.
    Coyer L; van Bilsen W; Bil J; Davidovich U; Hoornenborg E; Prins M; Matser A
    PLoS One; 2018; 13(10):e0205663. PubMed ID: 30312336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pleasure and PrEP: Pleasure-Seeking Plays a Role in Prevention Choices and Could Lead to PrEP Initiation.
    Mabire X; Puppo C; Morel S; Mora M; Rojas Castro D; Chas J; Cua E; Pintado C; Suzan-Monti M; Spire B; Molina JM; Préau M
    Am J Mens Health; 2019; 13(1):1557988319827396. PubMed ID: 30819060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between perceived barriers and benefits of using HIV pre-exposure prophylaxis and medication adherence among men who have sex with men in Western China.
    Hu Y; Zhong XN; Peng B; Zhang Y; Liang H; Dai JH; Zhang JY; Huang AL
    BMC Infect Dis; 2018 Nov; 18(1):575. PubMed ID: 30442106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV Pre-exposure Prophylaxis (PrEP) Uptake and Retention Among Men Who Have Sex with Men in a Community-Based Sexual Health Clinic.
    Hojilla JC; Vlahov D; Crouch PC; Dawson-Rose C; Freeborn K; Carrico A
    AIDS Behav; 2018 Apr; 22(4):1096-1099. PubMed ID: 29243109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-exposure Prophylaxis (PrEP) Use, Seroadaptation, and Sexual Behavior Among Men Who Have Sex with Men, San Francisco, 2004-2014.
    Chen YH; Snowden JM; McFarland W; Raymond HF
    AIDS Behav; 2016 Dec; 20(12):2791-2797. PubMed ID: 26983951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial.
    Zablotska IB; Selvey C; Guy R; Price K; Holden J; Schmidt HM; McNulty A; Smith D; Jin F; Amin J; Cooper DA; Grulich AE;
    BMC Public Health; 2018 Feb; 18(1):210. PubMed ID: 29394918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of interest in taking pre-exposure prophylaxis among men who have sex with men who used a rapid HIV-testing site in Montreal (Actuel sur Rue).
    Lebouché B; Engler K; Machouf N; Lessard D; Thomas R
    HIV Med; 2016 Feb; 17(2):152-8. PubMed ID: 26177691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation.
    Liu AY; Hessol NA; Vittinghoff E; Amico KR; Kroboth E; Fuchs J; Irvin R; Sineath RC; Sanchez T; Sullivan PS; Buchbinder SP
    AIDS Patient Care STDS; 2014 Dec; 28(12):622-7. PubMed ID: 25396706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Awareness and Acceptance of HIV Pre-exposure Prophylaxis among Medical Personnel and Men Who Have Sex with Men in Korea.
    Chang HH; Kim SW; Jung H; Lee SA; Park HK; Kim S; Lee JM; Choi JY
    J Korean Med Sci; 2018 Mar; 33(12):e91. PubMed ID: 29542300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Becoming adherent to a preventive treatment for HIV: a qualitative approach.
    Puppo C; Mabire X; Morel S; Laguette V; Rojas Castro D; Chas J; Cua E; Pintado C; Suzan-Monti M; Spire B; Molina JM; Préau M
    Psychol Health Med; 2020 Mar; 25(3):270-281. PubMed ID: 31294630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Willingness to use pre-exposure prophylaxis for HIV prevention among men who have sex with men in Malaysia: Findings from an online survey.
    Lim SH; Mburu G; Bourne A; Pang J; Wickersham JA; Wei CKT; Yee IA; Wang B; Cassolato M; Azwa I
    PLoS One; 2017; 12(9):e0182838. PubMed ID: 28902857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.